Endovascular Management of Aortic Arch Diseases: Current Status and Future Trends
Cardiology Discovery · 2022-12 · 2 (4) · 263-268
DOI: 10.1097/cd9.0000000000000080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Discovery, online erschienen am 10.11.2022. Verfasst von Chang Shu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Treatment of aortic arch (AA) diseases is challenging for surgeons. Conventional open surgery remains the “gold standard” but is associated with significant morbidity and mortality despite improvements in techniques. In the last 2 decades, thoracic endovascular aortic repair (TEVAR) has become the first-line treatment for diseases of the descending aorta, and its indications have expanded gradually. Various strategies have been proposed to preserve supra-aortic branches in TEVAR: hybrid technique, chimney technique, fenestration technique (including custom-made fenestrated or “scalloped” stent grafts, in situ fenestration, and physician-modified fenestration), and branched stent grafts. Though acceptable outcomes of endovascular aortic repair have been documented, the evidence regarding its long-term safety and efficacy is lacking, and concerns remain about the risk of cerebrovascular events, retrograde type-A dissection, endoleaks, and branch occlusion. This review discusses the current status and progress of endovascular repair of the AA, and looks toward future trends. We believe that multidisciplinary collaboration of a “HENDO” team (professionals in hybrid repair, endovascular repair, open surgery, cardiovascular anesthesia, and genetics) is essential for future repair of the AA to provide the optimal treatment.
Zitieren
APA
Shu, C., Li, J., Luo, M., Li, Q., & Fang, K. (2022). Endovascular Management of Aortic Arch Diseases: Current Status and Future Trends. Cardiology Discovery, 2(4), 263-268. https://doi.org/10.1097/cd9.0000000000000080
Vancouver
Shu C, Li J, Luo M, Li Q, Fang K. Endovascular Management of Aortic Arch Diseases: Current Status and Future Trends. Cardiology Discovery. 2022;2(4):263-268. doi:10.1097/cd9.0000000000000080
BibTeX
@article{Shu2022,
author = {Shu, Chang and Li, Jiehua and Luo, Mingyao and Li, Quanming and Fang, Kun},
title = {Endovascular Management of Aortic Arch Diseases: Current Status and Future Trends},
journal = {Cardiology Discovery},
year = {2022},
volume = {2},
number = {4},
pages = {263--268},
doi = {10.1097/cd9.0000000000000080}
}
EUVIMED